SCHEMBL7472870

SCHEMBL7472870

COc1nc2cc(Cl)c(Cl)c(NS(=O)(=O)c3ccccc3)c2nc1OC

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC40A1 Q9NP59 5/20 0.45
CCR4 P51679 3/20 0.44
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
TSHR P16473 2/20 0.43
PIK3CD O00329 1/20 0.43
KDM4E B2RXH2 4/20 0.43
HSD17B10 Q99714 2/20 0.43
LMNA P02545 1/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
RXFP1 Q9HBX9 1/20 0.42
HIF1A Q16665 1/20 0.42
PIK3CG P48736 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7466587 0.83 CCR4 (0.36) CCR4MAPTSMN1; SMN2PIK3CDKDM4E
SCHEMBL7462801 0.81 CCR4 (0.36) CCR4SMN1; SMN2PIK3CDHSD17B10LMNA
SCHEMBL7475650 0.73 CCR4 (0.35) CCR4MAPTPIK3CDKDM4EHSD17B10
SCHEMBL7467654 0.73 NPY1R (0.37) CCR4SMN1; SMN2TSHRPIK3CDHSD17B10
SCHEMBL7680466 0.73 CYP1A2 (0.39) MAPTSMN1; SMN2TSHRKDM4EHSD17B10
SCHEMBL7468793 0.72 CCR4 (0.36) CCR4SMN1; SMN2PIK3CDHIF1APIK3CG
SCHEMBL7476942 0.72 ALDH1A1 (0.38) SLC40A1CCR4MAPTSMN1; SMN2TSHR
SCHEMBL7468298 0.71 KMT2A (0.37) KDM4ELMNAMEN1KMT2A
SCHEMBL5475358 0.71 KDM4E (0.72) CCR4POLBMAPTSMN1; SMN2PIK3CD
SCHEMBL7682523 0.70 HRH4 (0.33) MAPTSMN1; SMN2TSHRHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0783495-B1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LTD (GB) 2002-02-27 EP disclosed
US-5852016-A Quinoxaline derivatives useful in therapy PFIZER INC. (US) 1998-12-22 US disclosed
WO-1996009295-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LIMITED (GB) 1996-03-28 WO disclosed